Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Committee OKs $57 Mil. Boost For NIH Translational Science Center

This article was originally published in The Tan Sheet

Executive Summary

The National Center for Advancing Translational Sciences would get a sizable chunk of the funding increase approved for NIH by the Senate Appropriations Committee, but support for increasing its budget is not universal.

You may also be interested in...



Translational Science Center Mission And Budget Draw Congress’ Scrutiny

House Appropriations subcommittee Republicans seem concerned about whether the National Center for Advancing Translational Sciences will step on industry toes, which could lead to a more tightened focus for the new NIH center’s funding in the fiscal 2013 budget.

US Senate Approves US-Mexico-Canada Agreement Championed By Industry

The US Senate overwhelmingly approved a bill on 16 January to implement the US-Mexico-Canada agreement, which includes a new chapter on the handling of medical devices supported by the medtech industry.

US Research Agency AHRQ Puts Out Call For Non-Pharma-Based Pain-Control Device Studies

The Agency for Healthcare Research and Quality (AHRQ) is conducting a review on treatments for acute pain and is asking device manufacturers and other organizations to supply it with studies on nonpharmacological therapies to control pain, including transcutaneous electrical nerve stimulation, ultrasound, heat- and cold-producing devices, and acupuncture.

Topics

UsernamePublicRestriction

Register

PS105814

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel